Eyenovia Open To All Strategic Option With Phase III Myopia Terminations

 
• By Joseph Haas
  
Eye in an high tech environment
Eyenovia is giving up on its pediatric myopia combo product
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from Rare Diseases